Tasci I, Naharci MI, Bozoglu E, Safer U, Aydogdu A, Yilmaz BF, et al
What Makes Semaglutide Different Uses a single hormone pathway (GLP-1) to support appetite control Often a great option for patients who prefer a more gradual approach Well-studied with a long track record in metabolic care What Makes Tirzepatide Different Activates two hormone pathways (GLP-1 and GIP) for broader metabolic support May provide stronger appetite suppression for some patients Often considered for patients who need additional metabolic support or have experienced plateaus What Clinical Trials Show GLP-1s Can Do The Proof in the Data Semaglutide By week 68, 86.4% lost at least 5%, 69.1% lost at least 10%, and 50.5% lost at least 15%
1 2 3 4 5 6 7 8 9 10 11 12 "GLP-1 drugs are transforming diabetes, obesity and more
Changing habits is a hard thing to suddenly do, but taking small steps to change the way you eat goes a long way in assisting with weight maintenance
This means the nutrients flow in slowly and steadily - no rushing or pressure